Table 1

- Patients and disease characteristics (N=38).

Characteristicsn (%)
Gender
Male19 (50.0)
Female19 (50.0)
Age at diagnosis, median (range)4 (0-72)
Age group
Up to 4 months20 (52.6)
4-12 months14 (36.8)
Over 12 months4 (10.5)
Diagnosis
Qatar24 (63.1)
Elsewhere14 (36.9)
Family history
Yes10 (26.3)
No28 (73.7)
Genetic analysis
Mutation in TSC11 (2.6)
Mutation in TSC233 (86.8)
Genetic studies negative4 (10.5)
Presentation
Infantile spasms14 (36.8)
Seizures (other than infantile spasms)18 (47.3)
Developmental delay5 (13.1)
Cardiac rhabdomyoma8 (21.0)
Hypopigmented spots5 (13.1)
Major criteria for TSC
Hypomelanotic nodules29 (76.3)
Angiofibroma20 (52.6)
Ungual fibroma0 (0.0))
Shagreen patch7 (18.4)
Retinal hamartoma5 (13.1)
Cortical dysplasia29 (76.3)
Subependymal nodules37 (97.3)
SEGA10 (26.3)
Cardiac rhabdomyoma16 (42.1)
LAM0 (0.0)
AML22 (57.8)
Minor criteria for TSC
Confetti lesions4 (10.5)
Dental enamel pits2 (5.3)
Intra-oral fibroma2 (5.3)
Retinal achromic patch0 (0.0)
Multiple renal cysts29 (76.3)
Non-renal hamartomas4 (10.5)
Neuro-imaging features
Tubers37 (97.3)
SEN37 (97.3)
SEGA10 (26.3)

Values are presented as numbers and percentages (%).

TSC: tuberous sclerosis complex, SEGA: subependymal giant cell astrocytoma, LAM: lymphangioleiomyomatosis, AML: angiomyolipoma, SEN: subependymal nodules